Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences

Immunology

Volumn 122, Issue 4, 2007, Pages 522-531

  Niazi, Kayvan R ^a   Ochoa, Maria Teresa ^b   Sieling, Peter A ^b   Rooke, Nanette E ^a   Peter, Anna K ^a   Mollahan, Pamela ^a   Dickey, Micah ^b   Rabizadeh, Shahrooz ^a   Rea, Thomas H ^c   Modlin, Robert L ^b  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antigen presentation processing; Humans; Major histocompatibility complex; T cells

Indexed keywords

CD1 ANTIGEN; HYBRID PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ENDOSOME; HUMAN; HUMAN CELL; LYSOSOME; PRIORITY JOURNAL; SEQUENCE ANALYSIS; T LYMPHOCYTE ACTIVATION;

ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; ANTIGENS, CD1; CD4-POSITIVE T-LYMPHOCYTES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENDOSOMES; EPITOPES, T-LYMPHOCYTE; GREEN FLUORESCENT PROTEINS; GROES PROTEIN; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERFERON-GAMMA, RECOMBINANT; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM LEPRAE; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 35948999345     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02666.x     Document Type: Article

References (39)

1. Trombetta ES, Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 2005 23: 975 1028.
2. Honey K, Rudensky AY. Lysosomal cysteine proteases regulate antigen presentation. Nat Rev Immunol 2003 3: 472 82.
3. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 1997 15: 821 50.
4. Pathak SS, Blum JS. Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules. Traffic 2000 1: 561 9.
5. Delvig AA, Robinson JH. Different endosomal proteolysis requirements for antigen processing of two T-cell epitopes of the M5 protein from viable Streptococcus pyogenes. J Biol Chem 1998 273: 3291 5.
6. Pinet VM, Long EO. Peptide loading onto recycling HLA-DR molecules occurs in early endosomes. Eur J Immunol 1998 28: 799 804.
7. Musson JA, Walker N, Flick-Smith H, Williamson ED, Robinson JH. Differential processing of CD4 T-cell epitopes from the protective antigen of Bacillus anthracis. J Biol Chem 2003 278: 52425 31.
8. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. Recognition of a lipid antigen by CD1-restricted αβ+ T cells. Nature 1994 372: 691 4.
9. Sieling PA, Chatterjee D, Porcelli SA et al. CD1-restricted T cell recognition of microbial lipoglycans. Science 1995 269: 227 30.
10. Moody DB, Reinhold BB, Guy MR et al. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 1997 278: 283 6.
11. Moody DB, Ulrichs T, Muhlecker W et al. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 2000 404: 884 8.
12. Kawano T, Cui J, Koezuka Y et al. CD1d-restricted and TCR-mediated activation of Valpha14 NKT cells by glycosylceramides. Science 1997 278: 1626 9.
13. Sugita M, Jackman RM, van Donselaar E et al. Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. Science 1996 273: 349 52.
14. Sugita M, Grant EP, van Donselaar E et al. Separate pathways for antigen presentation by CD1 molecules. Immunity 1999 11: 743 52.
15. Briken V, Jackman RM, Watts GF, Rogers RA, Porcelli SA. Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens. J Exp Med 2000 192: 281 8.
16. Prigozy TI, Sieling PA, Clemens D et al. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 1997 6: 187 97.
17. - T cells: B7-independent costimulation of CD1-restricted T cells. J Exp Med 1995 182: 2007 18.
18. Melian A, Geng YJ, Sukhova GK, Libby P, Porcelli SA. CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells. Am J Pathol 1999 155: 775 86.
19. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr 1966 34: 255 73.
20. Kim J, Sette A, Rodda S et al. Determinants of T cell reactivity to the Mycobacterium leprae GroES homologue. J Immunol 1997 159: 335 43.
21. Sugita MWN, Rogers RA, Peters PJ, Brenner MB. CD1c molecules broadly survey the endocytic system. Proc Natl Acad Sci USA 2000 97: 8445 50.
22. D'Souza-Schorey C, Li G, Colombo MI, Stahl PD. A regulatory role for ARF6 in receptor-mediated endocytosis. Science 1995 267: 1175 8.
23. Andre S, Seed B, Eberle J, Schraut W, Bultmann A, Haas J. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J Virol 1998 72: 1497 503.
24. Stenger S, Hanson DA, Teitlebaum R et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998 282: 121 5.
25. Rivoire B, Pessolani MC, Bozic CM et al. Chemical definition, cloning, and expression of the major protein of the leprosy bacillus. Infect Immun 1994 62: 2417 25.
26. Jackman RM, Stenger S, Lee A et al. The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity 1998 8: 341 51.
27. Aruffo A, Seed B. Expression of cDNA clones encoding the thymocyte antigens CD1a, b, c demonstrates a hierarchy of exclusion in fibroblasts. J Immunol 1989 143: 1723 30.
28. Peters PJ, Hsu VW, Ooi CE et al. Overexpression of wild-type and mutant ARF1 and ARF6: distinct perturbations of nonoverlapping membrane compartments. J Cell Biol 1995 128: 1003 17.
29. Amigorena S, Drake JR, Webster P, Mellman I. Transient accumulation of new class II MHC molecules in a novel. Nature 1994 369: 113 20.
30. Tulp A, Verwoerd D, Dobberstein B, Ploegh HL, Pieters J. Isolation and characterization of the intracellular MHC class II compartment. Nature 1994 369: 120 6.
31. Zhong G, Reis e Sousa C, Germain RN. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc Natl Acad Sci USA 1997 94: 13856 61.
32. Delvig AA, Robinson JH. Two T cell epitopes from the M5 protein of viable Streptococcus pyogenes engage different pathways of bacterial antigen processing in mouse macrophages. J Immunol 1998 160: 5267 72.
33. Stimac E, Lyons S, Pious D. Transcription of HLA class II genes in the absence of B-cell-specific octamer-binding factor. Mol Cell Biol 1988 8: 3734 9.
34. Chang CH, Fontes JD, Peterlin M, Flavell RA. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 1994 180: 1367 74.
35. Bonehill A, Heirman C, Thielemans K. Genetic approaches for the induction of a CD4+ T cell response in cancer immunotherapy. J Gene Med 2005 7: 686 95.
36. Rodriguez F, Harkins S, Redwine JM, de Pereda JM, Whitton JL. CD4(+) T cells induced by a DNA vaccine. Immunological consequences of epitope-specific lysosomal targeting. J Virol 2001 75: 10421 30.
37. Wu TC, Guarnieri FG, Staveley-O'Carroll KF et al. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proc Natl Acad Sci USA 1995 92: 11671 5.
38. Ji H, Wang TL, Chen CH et al. Targeting human papillomavirus type 16, E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16, E7-expressing tumors. Hum Gene Ther 1999: 10: 2727 40.
39. Arruda LB, Sim D, Chikhlikar PR et al. Dendritic cell-lysosomal- associated membrane protein (LAMP) and LAMP-1-HIV-1 gag chimeras have distinct cellular trafficking pathways and prime T and B cell responses to a diverse repertoire of epitopes. J Immunol 2006 177: 2265 75.